HUMAN PAPILLOMA VIRUS VACCINE

Course overview

THE 9-VALENT HUMAN PAPILLOMAVIRUS (HPV) VACCINE (9VHPV) IS A VACCINE USED IN THE MANAGEMENT AND PREVENTION OF INFECTION WITH HUMAN PAPILLOMAVIRUS (HPV) TYPES 6, 11, 16, 18, 31, 33, 45, 52, 58. IT IS IN THE IMMUNIZATION CLASS OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR THE 9-VALENT HUMAN PAPILLOMAVIRUS (HPV) VACCINE (9VHPV) AS A VALUABLE AGENT IN THE MANAGEMENT AND PREVENTION OF HPV INFECTION AND HPV-ASSOCIATED DISEASES. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS OF THE 9-VALENT HUMAN PAPILLOMAVIRUS (HPV) VACCINE (9VHPV) ADMINISTRATION PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH HPV IMMUNIZATION.